72 related articles for article (PubMed ID: 7908542)
1. Role of sympathetic cholinergic pathway in the neurogenous control of tissue-type plasminogen activator release into the blood.
Bashkov GV; Sergeev IYu ; Medvedeva NA
Blood Coagul Fibrinolysis; 1993 Dec; 4(6):993-8. PubMed ID: 7908542
[TBL] [Abstract][Full Text] [Related]
2. [The role of the sympathetic cholinergic pathway in the neurogenic control of the release of tissue-type plasminogen activator into the blood].
Bashkov GB; Sergeev IIu; Medvedeva NA; Makarov VA
Fiziol Zh SSSR Im I M Sechenova; 1992 May; 78(5):60-7. PubMed ID: 1334882
[TBL] [Abstract][Full Text] [Related]
3. [The stimulation of fibrinolysis during cholinergic vasodilating reactions].
Bashkov GV; Sergeev IIu; Medvedeva NA; Makarov VA
Fiziol Zh (1978); 1990; 36(4):3-8. PubMed ID: 2146171
[TBL] [Abstract][Full Text] [Related]
4. Release of tissue-type plasminogen activator (t-PA) in the splanchnic circulation of the anaesthetised pig during high sympathetic tone.
Björkman JA; Ilebekk A; Jern C
Thromb Res; 2010 Mar; 125(3):e106-9. PubMed ID: 19931890
[TBL] [Abstract][Full Text] [Related]
5. Cardiac sympathetic nerve stimulation triggers coronary t-PA release.
Björkman JA; Jern S; Jern C
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1091-7. PubMed ID: 12714432
[TBL] [Abstract][Full Text] [Related]
6. Sympathectomy decreases and adrenergic stimulation increases the release of tissue plasminogen activator (t-PA) from blood vessels: functional evidence for a neurologic regulation of plasmin production within vessel walls and other tissue matrices.
Peng T; Jiang X; Wang Y; Hand A; Gillies C; Cone RE; O'Rourke J
J Neurosci Res; 1999 Sep; 57(5):680-92. PubMed ID: 10462692
[TBL] [Abstract][Full Text] [Related]
7. Stimulated release of tissue plasminogen activator from artery wall sympathetic nerves: implications for stress-associated wall damage.
Hao Z; Jiang X; Sharafeih R; Shen S; Hand AR; Cone RE; O'Rourke J
Stress; 2005 Jun; 8(2):141-9. PubMed ID: 16019605
[TBL] [Abstract][Full Text] [Related]
8. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
Cruden NL; Tse GH; Fox KA; Ludlam CA; Megson I; Newby DE
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):772-7. PubMed ID: 15681300
[TBL] [Abstract][Full Text] [Related]
9. Modulation of sympathetic activity by tissue plasminogen activator is independent of plasminogen and urokinase.
Schaefer U; Vorlova S; Machida T; Melchor JP; Strickland S; Levi R
J Pharmacol Exp Ther; 2007 Jul; 322(1):265-73. PubMed ID: 17429057
[TBL] [Abstract][Full Text] [Related]
10. Enhanced tissue plasminogen activator synthesis by the sympathetic neurons that innervate aging vessels.
Jiang X; Hand AR; Shen S; Cone RE; O'Rourke J
J Neurosci Res; 2003 Feb; 71(4):567-74. PubMed ID: 12548713
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
12. Vascular and fibrinolytic effects of intra-arterial tumour necrosis factor-alpha in patients with coronary heart disease.
Robinson SD; Dawson P; Ludlam CA; Boon NA; Newby DE
Clin Sci (Lond); 2006 Mar; 110(3):353-60. PubMed ID: 16309383
[TBL] [Abstract][Full Text] [Related]
13. Sympathoadrenal activation and muscarinic receptor stimulation induce acute release of tissue-type plasminogen activator but not von Willebrand factor across the human forearm.
Jern C; Selin L; Tengborn L; Jern S
Thromb Haemost; 1997 Aug; 78(2):887-91. PubMed ID: 9268190
[TBL] [Abstract][Full Text] [Related]
14. Enhanced vascular plasminogen activator (t-PA) release by epinephrine in aged rats.
Iacoviello L; D'Adamo MC; De Curtis A; Buczko W; Donati MB
Thromb Haemost; 1995 May; 73(5):841-4. PubMed ID: 7482413
[TBL] [Abstract][Full Text] [Related]
15. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
16. Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans.
Chia S; Qadan M; Newton R; Ludlam CA; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):695-701. PubMed ID: 12692009
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological stimulation of t-PA release.
Klöcking HP; Markwardt F
Pharmazie; 1994 Apr; 49(4):227-30. PubMed ID: 7910971
[TBL] [Abstract][Full Text] [Related]
18. Evidence of a net release of tissue-type plasminogen activator across the human cerebral vasculature.
Jern C; Blomstrand C; Westerlind A
Thromb Haemost; 2004 May; 91(5):1019-25. PubMed ID: 15116264
[TBL] [Abstract][Full Text] [Related]
19. Secretion of tissue plasminogen activator and plasminogen activator inhibitor 1 during cardiopulmonary bypass.
Chandler WL; Velan T
Thromb Res; 2003; 112(3):185-92. PubMed ID: 14967416
[TBL] [Abstract][Full Text] [Related]
20. [Effect of chronic epaden administration on the tissue plasminogen activator activity in rabbits].
Petrukhina GN; Kalugin SA; Makarov VA; Gandel' VG
Eksp Klin Farmakol; 2000; 63(6):30-3. PubMed ID: 11202508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
